Research i_need_contribute
ATAS Acupuncture Reduces Chemotherapy Induced Fatigue in Breast Cancer
source:NCBI 2020-12-11 [Research]
Through Regulating ADROA1 Expression: A Randomized Sham-Controlled Pilot Trial

Yun-Fen Li,#1,* De-Quan Liu,#1,* Jian-Yun Nie,#1,* De-Dian Chen,#1,* Mei Yan,1 Zhen Zuo,2 Liang-Xian Liu,3 Wei-Yu Wang,4 Mian-Sheng Zhu,2,5 and Wen-Hui Li1

Yun-Fen Li

1The Third Affiliated Hospital of Kunming Medical University/Yunnan Cancer Hospital, Breast Cancer Surgery Department, Kunming, People’s Republic of China

Find articles by Yun-Fen Li

De-Quan Liu

1The Third Affiliated Hospital of Kunming Medical University/Yunnan Cancer Hospital, Breast Cancer Surgery Department, Kunming, People’s Republic of China

Find articles by De-Quan Liu

Jian-Yun Nie

1The Third Affiliated Hospital of Kunming Medical University/Yunnan Cancer Hospital, Breast Cancer Surgery Department, Kunming, People’s Republic of China

Find articles by Jian-Yun Nie

De-Dian Chen

1The Third Affiliated Hospital of Kunming Medical University/Yunnan Cancer Hospital, Breast Cancer Surgery Department, Kunming, People’s Republic of China

Find articles by De-Dian Chen

Mei Yan

1The Third Affiliated Hospital of Kunming Medical University/Yunnan Cancer Hospital, Breast Cancer Surgery Department, Kunming, People’s Republic of China

Find articles by Mei Yan

Zhen Zuo

2Yunnan University of Traditional Chinese Medicine, College of Acupuncture, Kunming, People’s Republic of China

Find articles by Zhen Zuo

Liang-Xian Liu

3Kunming Hospital of Traditional Chinese Medicine/The Third Affiliated Hospital of Yunnan University Traditional Chinese Medicine, Acupuncture Department, Kunming, People’s Republic of China

Find articles by Liang-Xian Liu

Wei-Yu Wang

4Servbus Technology (Beijing) Co., Ltd., Technical Service Department, Beijing, People’s Republic of China

Find articles by Wei-Yu Wang

Mian-Sheng Zhu

2Yunnan University of Traditional Chinese Medicine, College of Acupuncture, Kunming, People’s Republic of China

5ARIATAS, Association Pour la Recherche et l’Information de l’Acupuncture Time-Acupoints-Space, College of Acupuncture, Paris, France

Find articles by Mian-Sheng Zhu

Wen-Hui Li

1The Third Affiliated Hospital of Kunming Medical University/Yunnan Cancer Hospital, Breast Cancer Surgery Department, Kunming, People’s Republic of China

Find articles by Wen-Hui Li

 

1The Third Affiliated Hospital of Kunming Medical University/Yunnan Cancer Hospital, Breast Cancer Surgery Department, Kunming, People’s Republic of China

2Yunnan University of Traditional Chinese Medicine, College of Acupuncture, Kunming, People’s Republic of China

3Kunming Hospital of Traditional Chinese Medicine/The Third Affiliated Hospital of Yunnan University Traditional Chinese Medicine, Acupuncture Department, Kunming, People’s Republic of China

4Servbus Technology (Beijing) Co., Ltd., Technical Service Department, Beijing, People’s Republic of China

5ARIATAS, Association Pour la Recherche et l’Information de l’Acupuncture Time-Acupoints-Space, College of Acupuncture, Paris, France

#Contributed equally.

Correspondence: Mian-Sheng Zhu; Wen-Hui Li Email miansheng@wanadoo.fr; wenhuili2014@163.com

*These authors contributed equally to this work

 

 

 

Abstract

Objective

To investigate the feasibility and effectiveness of ATAS acupuncture (Acupoints-Time-Space Acupuncture) as a non-pharmacological intervention to prevent or relieve chemotherapy-induced fatigue in breast cancer patients undergoing taxane chemotherapy.

Methods

A pilot study in Kunming center with the aim of evaluating 40 patients randomized to 3 groups: ATAS, sham and non-acupuncture with an unequal randomization of 2:1:1. Participants with stage I–III breast cancer were scheduled to receive adjuvant EC4P4 chemotherapy. Participants in the ATAS and sham acupuncture arms received 20 sessions of acupuncture over 20 weeks, non-acupuncture arm received usual care. Evaluation scales, including VAS-F, MFI-20, HDAS, ISI, and blood samples were collected at four timepoints (T1-T4). mRNA sequencing was performed to detect the mechanism of acupuncture.

Results

A total of 581 sessions of acupuncture were performed on patients in the acupuncture group. There was no difference between the three groups in terms of clinical characteristics. Patients randomized to ATAS acupuncture had improved symptoms including fatigue, anxiety and insomnia during the whole process of chemotherapy compared with the other two groups. The VAS-F score of ATAS acupuncture group was decreased compared with non-acupuncture group (P=0.004). The score of MFI-20 in ATAS acupuncture group was kept at low level, while the other two groups’ scores kept climbing during chemotherapy (P=0.016; P=0.028, respectively). The mechanism of ATAS acupuncture which reduced fatigue and depression may be related to ADROA1, by regulating cGMP/PKG pathway.

Conclusion

This pilot study has demonstrated that ATAS acupuncture can significantly reduce fatigue induced by chemotherapy.

Trial Registration

Chinese Clinical Trials Registry, ChiCTR-IPR-17,013,652, registered Dec 3, 2017. http://www.chictr.org.cn/.

Protocol Version

Version 3.2 dated from 2018/04/20.

Keywords: early stage breast cancer, adjuvant chemotherapy, chemotherapy induced fatigue, ATAS